HCPLive Network

Genetic Variations Confer Risk for Multiple Psychiatric Disorders

THURSDAY, Feb. 28 (HealthDay News) -- Specific single nucleotide polymorphisms (SNPs) seem to confer risk of a diverse set of psychiatric disorders, according to a study published online Feb. 28 in The Lancet.

Jordan W. Smoller, MD, from Massachusetts General Hospital, in Boston, and colleagues from the Cross-Disorder Group of the Psychiatric Genomics Consortium examined genome-wide SNP data for autism spectrum disorder, attention-deficit/hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia in 33,332 cases and 27,888 controls of European ancestry. The allelic effects of each disorder were characterized.

In the primary analysis the researchers found that SNPs at four loci (regions on chromosomes 3p21 and 10q24 and within two L-type voltage-gated calcium channel subunits) exceeded the cut-off for genome-wide significance. The effects of these loci were supported for several disorders. Variable diagnostic specificity was seen for loci previously associated with bipolar disorder or schizophrenia. Based on polygenic risk score analysis there were cross-disorder associations, particularly between disorders with adult onset. For all five disorders, pathway analysis supported a role for genes in calcium channel signaling. Enrichment of brain-tissue expression quantitative trait loci was seen in SNPs with evidence of cross-disorder association.

"Our findings show that specific SNPs are associated with a range of psychiatric disorders of childhood onset or adult onset," the authors write. "These results provide evidence relevant to the goal of moving beyond descriptive syndromes in psychiatry, and towards a nosology informed by disease cause."

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Copyright © 2013 HealthDay. All rights reserved.

Further Reading
Following the presentation of a new research initiative designed to map the human brain, set out in the State of the Union address, the Obama administration has unveiled the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative, according to a White House press release issued April 2.
The new guidelines include evidence-based recommendations on the use of antidepressant medications, depression-focused psychotherapies, and somatic treatments.
A behavioral weight-loss intervention can lead to significant weight loss in overweight and obese adults with serious mental illness, according to a study published online March 21 in the New England Journal of Medicine.
Among those with mental disorders, left-handed patients are more likely to be diagnosed with psychotic conditions like schizophrenia than mood disorders like depression.
Patients who experience a head injury have an increased risk of receiving a subsequent diagnosis for a psychiatric disorder.
Childhood attention-deficit hyperactivity disorder (ADHD) has long-term consequences, with adults at increased risk for death from suicide and having one or more psychiatric disorders other than ADHD, according to a study published online March 4 in Pediatrics.
In 2011, nearly one in five adults in the United States reported any mental illness, and one in twenty suffered from serious mental illness, according to a Nov. 29 report published by the Substance Abuse and Mental Health Services Administration.
More Reading